The largest proportion – 39% – of the Group’s sales continues to be generated in Europe. The Emerging Markets region follows closely behind, accounting for 33% of Group sales. At Merck, Emerging Markets include Central and South America, and Asia except for Japan. North America generated 19% of Merck’s first-quarter sales while the region Rest of the World (ROW) was responsible for 9% of sales. ROW includes Japan, Australia/Oceania and Africa.
Merck Group | Sales by region – Q1

The Group’s first-quarter sales on an organic basis declined in Europe by 1.9% but rose 2.7% in North America. Organic sales growth was 4.2% in the Emerging Markets and 1.8% in the ROW region.
| XLS |
|
Merck Group | Growth components by region – Q1 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million/change in % |
Sales |
Organic |
Exchange rate effects |
Acquisitions/ |
Reported |
|
Europe |
1,000.1 |
–1.9% |
– |
1.1% |
–0.8% |
|
North America |
486.6 |
2.7% |
3.7% |
0.4% |
6.9% |
|
Emerging Markets |
844.6 |
4.2% |
1.7% |
– |
5.8% |
|
Rest of World |
232.6 |
1.8% |
5.2% |
0.6% |
7.6% |
|
Group |
2,563.9 |
1.2% |
1.7% |
0.6% |
3.5% |
As part of the comprehensive efficiency program made public in February, Merck announced plans on April 24 to close the Merck Serono Geneva headquarters site and reduce headcounts by 580 positions in Switzerland. Additionally, the company plans to transfer 620 positions from Geneva to Darmstadt, Boston and Beijing, with another 130 moving to other sites within Switzerland. Merck’s efficiency program is focused on addressing unprecedented market shifts, increasing competition in key product areas and existing inefficiencies within its own organization.
Merck had 40,542 employees worldwide on March 31, 2012, compared to 40,676 on December 31, 2011.
Merck Group | Number of employees as of March 31, 2012: 40,542

